Cergomex Imports, an over-the-counter drug manufacturer, refused FDA records requests for its Sanetto Hands Sanitizer Gel.
What happened
FDA sent electronic requests for records on August 16 and August 31, 2022, to the email in Cergomex’s registration file, then called on October 24, 2022 and asked for a response by October 31, 2022. The firm did not answer the emails or phone contacts, and FDA’s August 1, 2023 phone attempts were unsuccessful. FDA said the firm refused to provide records and it had no indication of quality assurance for drugs registered as manufactured at the facility.
What FDA found
The firm did not respond to FDA's August 16 and August 31, 2022 electronic requests for records about its drug manufacturing.
FD&C Act section 704(a)(4), 21 U.S.C. 374(a)(4)The firm refused to let FDA access or copy records, which the law treats as a prohibited act.
FD&C Act section 301(e), 21 U.S.C. 331(e)The firm did not respond to FDA's October 24, 2022 phone request or later phone attempts, including on August 1, 2023.
FDA had no indication of the level of quality assurance for drugs registered as manufactured at the firm's facility because the firm did not respond.
What FDA wants
FDA tells the firm to respond within 48 hours to confirm or update its registration and drug listing status and say whether it will provide the requested records; if it no longer makes drugs, it must delist all drugs and deregister the facility.
Who should pay attention
- companies that buy or distribute hand sanitizer from Cergomex
- OTC drug manufacturers with FDA registrations and listings
- quality teams managing FDA records requests and registration status
This is a summary. Read the original letter on fda.gov.